Amino Acid, Peptide, Polypeptide-Lipids (APPL) Derivatives and Uses Thereof
Described herein are compounds and compositions characterized, in certain embodiments, by conjugation of various groups, such as lipophilic groups, to an amino or amide group of an amino acid, a linear or cyclic peptide, a linear or cyclic polypeptide, or structural isomer thereof, to provide compounds of the present invention, collectively referred to herein as “APPLs”. Such APPLs are deemed useful for a variety of applications, such as, for example, improved nucleotide delivery. Exemplary APPLs include, but are not limited to, compounds of Formula (I), (II), (III), (IV), (V), and (VI), and salts thereof, as described herein:
Researchers
-
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Spain | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Mexico | Granted | 363,734 -
amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
United States of America | Granted | 9,512,073 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Canada | Granted | 2,853,522 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Chile | Granted | 61 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
China | Granted | 104,136,419 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
European Patent Convention | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Israel | Granted | 232,158 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Korea (south) | Published application -
amino acid-, peptide- and polypeptide-lipids, isomers, compositions, uses thereof
United States of America | Granted | 10,086,013 -
piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
Israel | Granted | 268,756 -
amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
United States of America | Granted | 10,682,374 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Australia | Granted | 2,012,328,570 -
amino acid, peptide, polypeptide-lipids (appl) derivatives and uses thereof
Australia | Granted | 2,017,265,103 -
amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
China | Granted | 0 -
piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
Israel | Granted | 259,414 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Mexico | Granted | 410,622 -
piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
Israel | Granted | 250,740 -
amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
Japan | Granted | 6,973,805 -
amino acid-, peptide- and polypeptide-lipids, isomers,
compositions, and uses thereof
Belgium | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
Korea (south) | Granted | 10 -
amino acid derivatives functionalized on the n-terminus capable of forming drug encapsulating microspheres and uses thereof
Australia | Granted | 2,020,201,387 -
amino acid derivatives functionalized on the n-terminus capable of forming drug encapsulating microspheres and uses thereof
Australia | Granted | 2,021,257,964 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
European Patent Convention | Published application -
amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
China | Published application -
amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
Japan | Granted | 7,527,650 -
amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
Hong Kong | Pending -
amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
United States of America | Granted | 11,458,158 -
amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
India | Granted | 521,029 -
amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
United States of America | Published application -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
United Kingdom | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
France | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Germany | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Netherlands | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Switzerland | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Liechtenstein | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Ireland | Granted | 2,771,319 -
amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres
Italy | Granted | 2,771,319
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.